Artificial Intelligence | Machine Learning Nucleai | AI-powered Precision Oncology Platform


Enterprise, Healthcare, Information Services, Pharma, Biomarkers, Digital Pathology Tel Aviv, TLV, Israel

Nucleai

Artificial Intelligence | Machine Learning


Nucleai | AI-powered Precision Oncology Platform

Nucleai

Healthcare, Information Services, Pharma, Biomarkers, Digital Pathology


Tel Aviv, TLV, Israel

The company is a leading provider of an AI-powered precision oncology platform transforming biomarker discovery and treatment decisions. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy, and improving patient care. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.

 

B2B

26 to 50

Series A

$11.5 M

Scaling Up

2017

 
 

Information Services
Healthcare

N/A

N/A

 
 

IT and Security

Yes

Active

 
 

   Machine Learning


Biomarker Development

Biomarker Development

Big Data

Big Data

CDx

CDx

Precision Health Platform

Precision Health Platform

Digital Pathology

Digital Pathology


Image

Image

Video

Video

Text

Text

Structured

Structured

 

   Software


N/A


Deep Learning Algorithm

Deep Learning Algorithm

Machine Learning Algorithm

Machine Learning Algorithm

 
 

View All

Director of HR

 

AI/ML Professionals

Want to work at Nucleai?

We can introduce you to the right person at Nucleai

Talk to our Talent Team

 

6

1

$33M

Company was founded 2017 and it took almost 5 years (Mar 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

03/23/2022

Series B

$33M

Section 32, Sanofi Ventures, Debiopharm Innovation Fund, Fosun RZ Capital, Vertex Ventures, Grove Ventures

Date : 03/23/2022

Round: Series B

$ Raised: $33M

Investors: Section 32, Sanofi Ventures, Debiopharm Innovation Fund, Fosun RZ Capital, Vertex Ventures, Grove Ventures

 

Investors

Interested in researching Nucleai?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Nucleai

Request a Demo - Deal Souring Platform

 
Avi Veidman

Avi Veidman
CEO

Eliron Amir

Eliron Amir
COO

Albert Achtenberg

Albert Achtenberg
CTO

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Nucleai